Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-07

FDA Approved: GLATIRAMER ACETATE — Original Application (Italfarmaco SpA)

View source ↗

Summary

The FDA approved Italfarmaco SpA's generic Glatiramer acetate via an Original Application (ANDA 208468). The product is for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

ORIG AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)